Item 8.01 Other Events
Domestic Issuer Status
As of June 30, 2020, the last business day of the second quarter of Zai Lab
Limited (the "Company"), the Company determined that it no longer qualified as a
foreign private issuer. As a result, effective January 1, 2021, the Company is
required to file periodic reports and registration statements on U.S. domestic
issuer forms with the Securities and Exchange Commission (the "SEC"), which are
more detailed and extensive in certain respects. In addition, the Company is
required to comply with U.S. proxy requirements. The Company is also no longer
eligible to rely upon exemptions from corporate governance requirements that are
available to foreign private issuers or to benefit from other accommodations for
foreign private issuers under the rules of the SEC or the Nasdaq. The Company's
next Annual Report for the year ended December 31, 2020 will be filed as a
domestic issuer, on Form 10-K.
Disclosure Channels to Disseminate Information
Investors and others should note that the Company may announce material
information about its finances, product candidates, clinical trials and other
matters to its investors using its investor relations website
(http://www.zailaboratory.com/in1/index.aspx) in addition to SEC filings, press
releases, public conference calls and webcasts. The Company uses these channels
to communicate with the Company's shareholders and the public about the Company
and other issues. It is possible that the information the Company posts on these
channels could be deemed to be material information. Therefore, the Company
encourages investors, the media, and others interested in the Company to review
the information it posts on the Company's investor relations website (referenced
above) in addition to following its press releases, SEC filings, public
conference calls, and webcasts.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses